ProCE Banner Activity

Slides From Leveraging GLP-1 Receptor Agonist Options to Advance Glycemic Goals in Type 2 Diabetes

Slideset Download
Learn about the appropriate use of GLP-1 RAs to address elevated A1C, obesity, and CV risk, as well as strategies to improve tolerability and adherence.

Released: December 23, 2019

Expiration: December 21, 2020

Share

Faculty

John Russell

John Russell, MD

Clinical Professor
Department of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel Medical College
Philadelphia, Pennsylvania
Program Director
Family Medicine Residency Program
Abington Hospital
Abington, Pennsylvania

Neil Skolnik

Neil Skolnik, MD

Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Abington, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc

Faculty Disclosure

Primary Author

John Russell, MD

Clinical Professor
Department of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel Medical College
Philadelphia, Pennsylvania
Program Director
Family Medicine Residency Program
Abington Hospital
Abington, Pennsylvania

Neil Skolnik, MD

Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Abington, Pennsylvania